Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6948508> ?p ?o }
Showing triples 1 to 43 of
43
with 100 triples per page.
- Q6948508 subject Q8343807.
- Q6948508 subject Q8645495.
- Q6948508 subject Q8729038.
- Q6948508 subject Q8965786.
- Q6948508 subject Q9056368.
- Q6948508 abstract "Myrophine (Myristylbenzylmorphine) is an opiate analogue that was developed in 1952. It is a derivative of morphine. Myrophine is substituted with a 3-benzyl group and a 6-myristyl chain. It is metabolised to form benzylmorphine and then further to morphine, and so is a long-acting prodrug for morphine, but with a slow onset of effects. It is weaker than morphine as an analgesic but longer lasting in effects, and was thought to have more local anesthetic effect than morphine, though with a somewhat greater tendency to cause histamine reactions like itching and rash. In addiction studies conducted in human subjects in the 1950s, myrophine did not substitute for morphine in withdrawal, did not produce notable morphine-like effects, and did not produce addiction or dependence regardless of dose or how it was administered. Consequently it was thought to be useful in treating pain in addicts who were being detoxified from other opioid drugs.It is a Schedule I drug in the USA, considered to have high potential for abuse and no medical applications, and is controlled under international drug conventions. Myrophine is almost invariably used as the hydrochloride (free base conversion ratio 0.94) and has a DEA Administrative Controlled Substance Control Number of 9308.Myrophine is a Class A controlled substance in the UK, and is on the UN's Yellow list.".
- Q6948508 atcPrefix "none".
- Q6948508 casNumber "467-18-5".
- Q6948508 chEBI "59860".
- Q6948508 fdaUniiCode "417TUP54OL".
- Q6948508 iupacName "7,8-didehydro-4,5α-epoxy-17-methyl-3-(phenylmethoxy)-morphinan-6-ol tetradecanoate".
- Q6948508 pubchem "5362457".
- Q6948508 thumbnail Myrophine_structure.png?width=300.
- Q6948508 wikiPageWikiLink Q173235.
- Q6948508 wikiPageWikiLink Q1868462.
- Q6948508 wikiPageWikiLink Q2026938.
- Q6948508 wikiPageWikiLink Q4083783.
- Q6948508 wikiPageWikiLink Q422658.
- Q6948508 wikiPageWikiLink Q603741.
- Q6948508 wikiPageWikiLink Q61233.
- Q6948508 wikiPageWikiLink Q81225.
- Q6948508 wikiPageWikiLink Q818534.
- Q6948508 wikiPageWikiLink Q8343807.
- Q6948508 wikiPageWikiLink Q8645495.
- Q6948508 wikiPageWikiLink Q8729038.
- Q6948508 wikiPageWikiLink Q8965786.
- Q6948508 wikiPageWikiLink Q9056368.
- Q6948508 wikiPageWikiLink Q928770.
- Q6948508 wikiPageWikiLink Q940.
- Q6948508 atcPrefix "none".
- Q6948508 casNumber "467".
- Q6948508 chebi "59860".
- Q6948508 iupacName "78".
- Q6948508 pubchem "5362457".
- Q6948508 unii "417".
- Q6948508 type ChemicalSubstance.
- Q6948508 type Drug.
- Q6948508 type ChemicalObject.
- Q6948508 type Thing.
- Q6948508 type Q8386.
- Q6948508 comment "Myrophine (Myristylbenzylmorphine) is an opiate analogue that was developed in 1952. It is a derivative of morphine. Myrophine is substituted with a 3-benzyl group and a 6-myristyl chain. It is metabolised to form benzylmorphine and then further to morphine, and so is a long-acting prodrug for morphine, but with a slow onset of effects.".
- Q6948508 label "Myrophine".
- Q6948508 depiction Myrophine_structure.png.